Acumen Pharmaceuticals, Inc. (ABOS)

NASDAQ: ABOS · Real-Time Price · USD

1.250

+0.040 (3.31%)

At close: Jul 9, 2025, 4:00 PM

1.220

-0.030 (-2.38%)

After-hours: Jul 9, 2025, 4:31 PM EDT

Acumen Pharmaceuticals Employees

Acumen Pharmaceuticals had 61 employees as of December 31, 2024. The number of employees increased by 9 or 17.31% compared to the previous year.

Employees

61

Change (1Y)

9

Growth (1Y)

17.31%

Revenue / Employee

n/a

Profits / Employee

-$1,905,770

Market Cap

75.72M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	61	9	17.31%
Dec 31, 2023	52	12	30.00%
Dec 31, 2022	40	23	135.29%
Dec 31, 2021	17	10	142.86%
Dec 31, 2020	7	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	94,300
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

ABOS News

2 months ago - Acumen Pharmaceuticals, Inc. (ABOS) Q1 2025 Earnings Call Transcript - Seeking Alpha
2 months ago - Acumen Pharmaceuticals to Participate in the Bank of America Healthcare Conference - GlobeNewsWire
2 months ago - Acumen Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025 - GlobeNewsWire
3 months ago - Acumen Pharmaceuticals Showcases pTau217 Trial Screening Progress in Phase 2 ALTITUDE-AD Trial and Preclinical Research Methods at AD/PD 2025 and AAN Annual Meeting - GlobeNewsWire
3 months ago - Acumen Pharmaceuticals, Inc. (ABOS) Q4 2024 Earnings Call Transcript - Seeking Alpha
3 months ago - Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025 - GlobeNewsWire
4 months ago - Acumen Pharmaceuticals CEO Discusses Novel Targeted Therapies for Alzheimer's - GlobeNewsWire
4 months ago - Acumen Pharmaceuticals to Present During International Conference on Alzheimer's and Parkinson's Diseases 2025 and American Academy of Neurology Annual Meeting - GlobeNewsWire